These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32121190)

  • 1. A Method for the Prediction of Clinical Outcome Using Diffusion Magnetic Resonance Imaging: Application on Parkinson's Disease.
    Tsai CC; Lin YC; Ng SH; Chen YL; Cheng JS; Lu CS; Weng YH; Lin SH; Chen PY; Wu YM; Wang JJ
    J Clin Med; 2020 Feb; 9(3):. PubMed ID: 32121190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of the Clinical Severity of Progressive Supranuclear Palsy by Diffusion Tensor Imaging.
    Chen YL; Zhao XA; Ng SH; Lu CS; Lin YC; Cheng JS; Tsai CC; Wang JJ
    J Clin Med; 2019 Dec; 9(1):. PubMed ID: 31878122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of olfactory tract in Parkinson's disease: a DTI tractography study.
    Nigro P; Chiappiniello A; Simoni S; Paolini Paoletti F; Cappelletti G; Chiarini P; Filidei M; Eusebi P; Guercini G; Santangelo V; Tarducci R; Calabresi P; Parnetti L; Tambasco N
    Neuroradiology; 2021 Feb; 63(2):235-242. PubMed ID: 32918150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of diffusion tensor MRI parameters in the brains of patients with Parkinson's disease compared with normal brains: possible diagnostic use.
    Lu CS; Ng SH; Weng YH; Cheng JS; Lin WY; Wai YY; Chen YL; Wang JJ
    Eur Radiol; 2016 Nov; 26(11):3978-3988. PubMed ID: 26945764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.
    Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K
    Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep learning based diagnosis of Parkinson's Disease using diffusion magnetic resonance imaging.
    Zhao H; Tsai CC; Zhou M; Liu Y; Chen YL; Huang F; Lin YC; Wang JJ
    Brain Imaging Behav; 2022 Aug; 16(4):1749-1760. PubMed ID: 35285004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease.
    Theisen F; Leda R; Pozorski V; Oh JM; Adluru N; Wong R; Okonkwo O; Dean DC; Bendlin BB; Johnson SC; Alexander AL; Gallagher CL
    Neuroimage Clin; 2017; 16():557-563. PubMed ID: 28971007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detecting dopaminergic neuronal degeneration using diffusion tensor imaging in a rotenone-induced rat model of Parkinson's disease: fractional anisotropy and mean diffusivity values.
    Liu LX; Du D; Zheng T; Fang Y; Chen YS; Yi HL; He QY; Gao DW; Shi QL
    Neural Regen Res; 2017 Sep; 12(9):1485-1491. PubMed ID: 29089995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free-water imaging in Parkinson's disease and atypical parkinsonism.
    Planetta PJ; Ofori E; Pasternak O; Burciu RG; Shukla P; DeSimone JC; Okun MS; McFarland NR; Vaillancourt DE
    Brain; 2016 Feb; 139(Pt 2):495-508. PubMed ID: 26705348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine Learning Models for Diagnosis of Parkinson's Disease Using Multiple Structural Magnetic Resonance Imaging Features.
    Ya Y; Ji L; Jia Y; Zou N; Jiang Z; Yin H; Mao C; Luo W; Wang E; Fan G
    Front Aging Neurosci; 2022; 14():808520. PubMed ID: 35493923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of mean diffusivity in brain white matter and deep gray matter in Parkinson's disease.
    Kim HJ; Kim SJ; Kim HS; Choi CG; Kim N; Han S; Jang EH; Chung SJ; Lee CS
    Neurosci Lett; 2013 Aug; 550():64-8. PubMed ID: 23831353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's disease outcomes after intraoperative CT-guided "asleep" deep brain stimulation in the globus pallidus internus.
    Mirzadeh Z; Chapple K; Lambert M; Evidente VG; Mahant P; Ospina MC; Samanta J; Moguel-Cobos G; Salins N; Lieberman A; Tröster AI; Dhall R; Ponce FA
    J Neurosurg; 2016 Apr; 124(4):902-7. PubMed ID: 26452116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.
    Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S
    J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation.
    Latourelle JC; Beste MT; Hadzi TC; Miller RE; Oppenheim JN; Valko MP; Wuest DM; Church BW; Khalil IG; Hayete B; Venuto CS
    Lancet Neurol; 2017 Nov; 16(11):908-916. PubMed ID: 28958801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature.
    Péran P; Cherubini A; Assogna F; Piras F; Quattrocchi C; Peppe A; Celsis P; Rascol O; Démonet JF; Stefani A; Pierantozzi M; Pontieri FE; Caltagirone C; Spalletta G; Sabatini U
    Brain; 2010 Nov; 133(11):3423-33. PubMed ID: 20736190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
    Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
    J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Assessment of Diffusion Parameters and Cerebral Blood Flow Within Basal Ganglia in Early Parkinson's Disease.
    Pelizzari L; Laganà MM; Di Tella S; Rossetto F; Bergsland N; Nemni R; Clerici M; Baglio F
    Front Aging Neurosci; 2019; 11():134. PubMed ID: 31214017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life and Parkinson's disease: Philippine translation and validation of the Parkinson's disease questionnaire.
    Suratos CTR; Saranza GRM; Sumalapao DEP; Jamora RDG
    J Clin Neurosci; 2018 Aug; 54():156-160. PubMed ID: 29907384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging brain iron and diffusion patterns: a follow-up study of Parkinson's disease in the initial stages.
    Rossi ME; Ruottinen H; Saunamäki T; Elovaara I; Dastidar P
    Acad Radiol; 2014 Jan; 21(1):64-71. PubMed ID: 24331266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.
    Stocchi F; Rascol O; Destee A; Hattori N; Hauser RA; Lang AE; Poewe W; Stacy M; Tolosa E; Gao H; Nagel J; Merschhemke M; Graf A; Kenney C; Trenkwalder C
    Mov Disord; 2013 Nov; 28(13):1838-46. PubMed ID: 23853029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.